These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30848114)

  • 1. Monoclonal gammopathy of renal significance: clinical manifestation, pathogenic characteristic and treatment.
    Cao Q; Qi H; Yao L; Liu Q
    Panminerva Med; 2020 Mar; 62(1):38-53. PubMed ID: 30848114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update to the pathogenesis for monoclonal gammopathy of renal significance.
    Zuo C; Zhu Y; Xu G
    Crit Rev Oncol Hematol; 2020 May; 149():102926. PubMed ID: 32199132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysproteinemias and Glomerular Disease.
    Leung N; Drosou ME; Nasr SH
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):128-139. PubMed ID: 29114004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of monoclonal gammopathy of renal significance.
    Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
    Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
    Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
    Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
    Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
    Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review.
    Huang J; Sun C; Su H; Zhang C; Xiong J
    Kidney Blood Press Res; 2019; 44(4):858-869. PubMed ID: 31352451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
    Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
    Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
    Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
    Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
    Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
    Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
    Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
    Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
    Sethi S; Rajkumar SV; D'Agati VD
    J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
    Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
    Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment].
    Smirnov AV; Afanasyev BV; Poddubnaya IV; Dobronravov VA; Khrabrova MS; Zakharova EV; Nikitin EA; Lysenko Kozlovskaya LV; Bobkova IN; Rameev VV; Batyushin MM; Moiseev IS; Darskaya EI; Pirogova OV; Mendeleeva LP; Biryukova LS
    Ter Arkh; 2020 Sep; 92(7):10-22. PubMed ID: 33346441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
    Gomes-Alves I; Castro-Ferreira I
    Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
    Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
    Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.
    Rosner MH; Edeani A; Yanagita M; Glezerman IG; Leung N;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2280-2287. PubMed ID: 27526705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and management of monoclonal gammopathy of renal significance.
    Jain A; Haynes R; Kothari J; Khera A; Soares M; Ramasamy K
    Blood Adv; 2019 Aug; 3(15):2409-2423. PubMed ID: 31409583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
    Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
    Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.